Page last updated: 2024-10-28

ha14-1 and Granulocytic Leukemia

ha14-1 has been researched along with Granulocytic Leukemia in 1 studies

ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate: a BH3 mimetic; synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ren, Y1
Chen, Z1
Chen, L1
Woods, NT1
Reuther, GW1
Cheng, JQ1
Wang, HG1
Wu, J1

Other Studies

1 other study available for ha14-1 and Granulocytic Leukemia

ArticleYear
Shp2E76K mutant confers cytokine-independent survival of TF-1 myeloid cells by up-regulating Bcl-XL.
    The Journal of biological chemistry, 2007, Dec-14, Volume: 282, Issue:50

    Topics: Amino Acid Substitution; Apoptosis; bcl-X Protein; Benzopyrans; Cell Line; Cell Survival; Chlorpropa

2007